To validate these clinical data in an independent cohort, we evaluated SEMA3C mRNA expression in a publicly available pancreatic ductal adenocarcinoma dataset of The Cancer Genome Atlas (TCGA-PAAD) [11]. The gene discussed is SEMA3C; the disease is pancreatic ductal adenocarcinoma.